Lars Fruergaard Jørgensen
Novo Nordisk CEO and Board Leadership Step Down Amid Market Pressures; New Board to Prioritize Faster Decision-Making
Novo Nordisk; CEO resignation; Lars Fruergaard Jørgensen; board leadership change; Novo Nordisk Foundation; share price decline; strategic decision-making; competition; Lars Rebien Sørensen; executive transition
Novo Nordisk CEO Departs Amid Weight-Loss Drug Market Pressures; Flagship Biotech Appoints CEO from Scholar Rock
Novo Nordisk; CEO departure; Lars Fruergaard Jørgensen; obesity drugs; weight-loss market; Eli Lilly competition; market challenges; Flagship Biotech; CEO appointment; Scholar Rock